BLOCK DRUGS' CAFFREE ANTI-STAIN FLUORIDE TOOTHPASTE
BLOCK DRUGS' CAFFREE ANTI-STAIN FLUORIDE TOOTHPASTE will get $6 mil. in first-year TV ad support beginning this month, a company spokesperson said. Block's new Caffree fluoride toothpaste and gel for tea and coffee stains is now launching nationally. TV ads for the brand broke the week of Sept. 11. TV ads and package materials claim Caffree "decaffeinates your smile," with "three special ingredients to get out coffee and tea stains better than the leading toothpaste." Ads also note that caffeine stains can "be even more of a problem than tobacco stains." In unpublished studies not cited in promotional materials, the company tested Caffree against Crest and Topol Smokers' Toothpaste, Block said. Caffree is Block's third dentifrice product, but its first cosmetically positioned one. The company also markets Sensodyne and Promise dentifrices for desensitizing teeth and gums. Block estimates that anti-stain toothpastes hold a 4% to 5% share of the total toothpaste market. Dep recently repositioned Topol to highlight the toothpaste's cosmetic anti-stain benefits and to broaden Topol's appeal beyond the shrinking smokers' market.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth